Connor S. Clairmont

911 total citations
13 papers, 626 citations indexed

About

Connor S. Clairmont is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Connor S. Clairmont has authored 13 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 3 papers in Plant Science. Recurrent topics in Connor S. Clairmont's work include DNA Repair Mechanisms (13 papers), PARP inhibition in cancer therapy (9 papers) and CRISPR and Genetic Engineering (7 papers). Connor S. Clairmont is often cited by papers focused on DNA Repair Mechanisms (13 papers), PARP inhibition in cancer therapy (9 papers) and CRISPR and Genetic Engineering (7 papers). Connor S. Clairmont collaborates with scholars based in United States, Mexico and Finland. Connor S. Clairmont's co-authors include Alan D. D’Andrea, Stephen J. Elledge, Richard O. Adeyemi, Prabha Sarangi, Kristen E. Mengwasser, Karthikeyan Ponnienselvan, Mei Yuk Choi, Yumei Leng, Lisa A. Moreau and Dipanjan Chowdhury and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Molecular Cell.

In The Last Decade

Connor S. Clairmont

13 papers receiving 624 citations

Peers

Connor S. Clairmont
Mark A. Villamil United States
Gina M. Kavanaugh United States
Renier Vélez-Cruz United States
Serguei R. Romanov United States
Jan Benada Denmark
Connor S. Clairmont
Citations per year, relative to Connor S. Clairmont Connor S. Clairmont (= 1×) peers Þorkell Guðjόnsson

Countries citing papers authored by Connor S. Clairmont

Since Specialization
Citations

This map shows the geographic impact of Connor S. Clairmont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Connor S. Clairmont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Connor S. Clairmont more than expected).

Fields of papers citing papers by Connor S. Clairmont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Connor S. Clairmont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Connor S. Clairmont. The network helps show where Connor S. Clairmont may publish in the future.

Co-authorship network of co-authors of Connor S. Clairmont

This figure shows the co-authorship network connecting the top 25 collaborators of Connor S. Clairmont. A scholar is included among the top collaborators of Connor S. Clairmont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Connor S. Clairmont. Connor S. Clairmont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Khodaverdian, Varandt Y., et al.. (2024). REV1 coordinates a multi-faceted tolerance response to DNA alkylation damage and prevents chromosome shattering in Drosophila melanogaster. PLoS Genetics. 20(7). e1011181–e1011181. 1 indexed citations
2.
Iyer, Divya, Connor S. Clairmont, Huy Nguyen, et al.. (2022). CCAR2 functions downstream of the Shieldin complex to promote double-strand break end-joining. Proceedings of the National Academy of Sciences. 119(49). e2214935119–e2214935119. 5 indexed citations
3.
Li, Feng, Prabha Sarangi, Divya Iyer, et al.. (2022). CHAMP1 binds to REV7/FANCV and promotes homologous recombination repair. Cell Reports. 40(9). 111297–111297. 13 indexed citations
4.
Färkkilä, Anniina, Alfredo Rodríguez, Jaana Oikkonen, et al.. (2021). Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in TP53- and BRCA1 -Deficient Cells. Cancer Research. 81(10). 2774–2787. 19 indexed citations
5.
Clairmont, Connor S. & Alan D. D’Andrea. (2021). REV7 directs DNA repair pathway choice. Trends in Cell Biology. 31(12). 965–978. 30 indexed citations
6.
Adeyemi, Richard O., Nicholas A. Willis, Andrew E. H. Elia, et al.. (2021). The Protexin complex counters resection on stalled forks to promote homologous recombination and crosslink repair. Molecular Cell. 81(21). 4440–4456.e7. 18 indexed citations
7.
Clairmont, Connor S., Prabha Sarangi, Karthikeyan Ponnienselvan, et al.. (2020). TRIP13 regulates DNA repair pathway choice through REV7 conformational change. Nature Cell Biology. 22(1). 87–96. 108 indexed citations
8.
Sarangi, Prabha, Connor S. Clairmont, & Alan D. D’Andrea. (2020). Disassembly of the Shieldin Complex by TRIP13. Cell Cycle. 19(13). 1565–1575. 9 indexed citations
9.
Sarangi, Prabha, et al.. (2020). p31 comet promotes homologous recombination by inactivating REV7 through the TRIP13 ATPase. Proceedings of the National Academy of Sciences. 117(43). 26795–26803. 24 indexed citations
10.
Mengwasser, Kristen E., Richard O. Adeyemi, Yumei Leng, et al.. (2019). Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. Molecular Cell. 73(5). 885–899.e6. 143 indexed citations
11.
Lim, Kah Suan, Emma A. Roberts, Emily F. Gaudiano, et al.. (2018). USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors. Molecular Cell. 72(6). 925–941.e4. 127 indexed citations
12.
Bluteau, Dominique, Julien Masliah-Planchon, Connor S. Clairmont, et al.. (2016). Biallelic inactivation of REV7 is associated with Fanconi anemia. Journal of Clinical Investigation. 126(9). 3580–3584. 105 indexed citations
13.
Senejani, Alireza G., Shibani Dalal, Yanfeng Liu, et al.. (2012). Y265C DNA polymerase beta knockin mice survive past birth and accumulate base excision repair intermediate substrates. Proceedings of the National Academy of Sciences. 109(17). 6632–6637. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026